Matches in SemOpenAlex for { <https://semopenalex.org/work/W2994812513> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W2994812513 endingPage "S716" @default.
- W2994812513 startingPage "S715" @default.
- W2994812513 abstract "To track and evaluate AIFA Technical Scientific Committee approach on innovativeness assessment, based on recently issued new criteria. CTS outcomes on drugs innovativeness, published on AIFA website from April 2017 to February 2019, were collected and categorized according to: i) kind of innovativeness: full, conditional or no innovativeness; ii) orphan designation; iii) therapeutic area: oncological vs non-oncological drugs. For each single indication assessed for innovativeness, the ranking of the three criteria (therapeutic unmet need maximum to absent, added therapeutic value maximum to absent, and quality of evidences high to very low) was analyzed. Sub-analyses according to the three categories were also run. Out of forty-one indications assessed by AIFA for innovativeness (and corresponding to 30 drugs), 12 (29%) were granted full innovative status, 14 (34%) obtained the conditional innovativeness and the remaining 15 (37%) were assessed as not innovative (7 orphan and 8 oncological indications). 50% of full innovative indications referred to orphan drugs (6/12) and 42% to oncological diseases (5/12); regarding conditionally innovative indications, 29% were for orphan drugs (4/14) and 79% (11/14) for oncological ones. Analysing innovativeness criteria application, AIFA have never recognized the maximum grading for added therapeutic value; moreover, focusing on fully innovative indications, 9 out of 12 (75%) did not meet all the three criteria thresholds stated by AIFA decree. This analysis highlighted that there is no strict matching between AIFA criteria (as reported by AIFA decree) and the granting of full innovative status. In fact, most of the analysed cases are borderline situations (full vs. conditional innovativeness) and have been assessed case-by-case, leaving a shade of subjectivity that gives innovativeness decision-making process a margin of flexibility. The limited sample does not let us make conclusions on the impact of orphan designation or oncological setting." @default.
- W2994812513 created "2019-12-26" @default.
- W2994812513 creator A5041532457 @default.
- W2994812513 creator A5070307311 @default.
- W2994812513 creator A5079497153 @default.
- W2994812513 creator A5089629359 @default.
- W2994812513 date "2019-11-01" @default.
- W2994812513 modified "2023-09-28" @default.
- W2994812513 title "PMU44 FIFTY SHADES OF... INNOVATIVENESS IN ITALY" @default.
- W2994812513 doi "https://doi.org/10.1016/j.jval.2019.09.1663" @default.
- W2994812513 hasPublicationYear "2019" @default.
- W2994812513 type Work @default.
- W2994812513 sameAs 2994812513 @default.
- W2994812513 citedByCount "0" @default.
- W2994812513 crossrefType "journal-article" @default.
- W2994812513 hasAuthorship W2994812513A5041532457 @default.
- W2994812513 hasAuthorship W2994812513A5070307311 @default.
- W2994812513 hasAuthorship W2994812513A5079497153 @default.
- W2994812513 hasAuthorship W2994812513A5089629359 @default.
- W2994812513 hasBestOaLocation W29948125131 @default.
- W2994812513 hasConcept C127413603 @default.
- W2994812513 hasConcept C144133560 @default.
- W2994812513 hasConcept C147176958 @default.
- W2994812513 hasConcept C17744445 @default.
- W2994812513 hasConcept C199539241 @default.
- W2994812513 hasConcept C2777286243 @default.
- W2994812513 hasConcept C2778958867 @default.
- W2994812513 hasConcept C60644358 @default.
- W2994812513 hasConcept C71924100 @default.
- W2994812513 hasConcept C75480439 @default.
- W2994812513 hasConcept C86803240 @default.
- W2994812513 hasConceptScore W2994812513C127413603 @default.
- W2994812513 hasConceptScore W2994812513C144133560 @default.
- W2994812513 hasConceptScore W2994812513C147176958 @default.
- W2994812513 hasConceptScore W2994812513C17744445 @default.
- W2994812513 hasConceptScore W2994812513C199539241 @default.
- W2994812513 hasConceptScore W2994812513C2777286243 @default.
- W2994812513 hasConceptScore W2994812513C2778958867 @default.
- W2994812513 hasConceptScore W2994812513C60644358 @default.
- W2994812513 hasConceptScore W2994812513C71924100 @default.
- W2994812513 hasConceptScore W2994812513C75480439 @default.
- W2994812513 hasConceptScore W2994812513C86803240 @default.
- W2994812513 hasLocation W29948125131 @default.
- W2994812513 hasOpenAccess W2994812513 @default.
- W2994812513 hasPrimaryLocation W29948125131 @default.
- W2994812513 hasRelatedWork W1506200166 @default.
- W2994812513 hasRelatedWork W1995515455 @default.
- W2994812513 hasRelatedWork W2080531066 @default.
- W2994812513 hasRelatedWork W2378754580 @default.
- W2994812513 hasRelatedWork W2748952813 @default.
- W2994812513 hasRelatedWork W2899084033 @default.
- W2994812513 hasRelatedWork W3031052312 @default.
- W2994812513 hasRelatedWork W3032375762 @default.
- W2994812513 hasRelatedWork W3108674512 @default.
- W2994812513 hasRelatedWork W4246804560 @default.
- W2994812513 hasVolume "22" @default.
- W2994812513 isParatext "false" @default.
- W2994812513 isRetracted "false" @default.
- W2994812513 magId "2994812513" @default.
- W2994812513 workType "article" @default.